MarketInOut Stock Screener Log In | Sign Up
 

Recursion Pharmaceuticals Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 09/11/2026
Recursion Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,716.07 mln
Float511 mln
Earnings Date11/11/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-4.98
Highly reliable

1-Year Forecast

7.22
Transformational upside

Relative Strength

21 / 100
Significantly lagging

Debt / Equity

0.07
Debt-free

Pre-Tax Margin

-970%
Severely loss-making

Business Description

Recursion Pharmaceuticals is a US and UK-based drug discovery company that combines biology, chemistry, automation, and data science to find new treatments more efficiently than traditional methods allow. Founded in 2013 and headquartered in Salt Lake City, Utah, the company is currently running multiple clinical trials targeting cancers, rare genetic conditions, and blood disorders. Recursion works alongside major pharmaceutical partners including Roche, Sanofi, Bayer, and Takeda to advance its pipeline of experimental medicines.

Key Fundamentals

EPS-1.00
ROE-51.51
RPS0.11
ROIC-72.60
ROA-38.56
Interest Cover-365
EBITDA, mln-444
EV / EBITDA-2.98
EV / EBIT-2.54
Revenue, mln53.94
EV / Revenue24.55

Financial Strength

Altman Z-Score0.05
Piotroski F-Score 5 / 9
Beneish M-Score-4.98
1-Year Target Price7.22
Short Ratio11.67
Short % of Float35.03

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -6.98% 15 / 100   
1 Month -2.74% 39 / 100   
2 Months -15.79% 21 / 100   
6 Months -2.74% 33 / 100   
1 Year -29.52% 22 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us